Adirondack Trust Company’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
HWAM
AWA
VCM
NAM
FFA
EWP
TWD
GI
EP
Adirondack Trust Company's NVCR Position: Q3 2026 in Review
Adirondack Trust Company held its NovoCure (NVCR) position steady in Q3 2026 at 100 shares worth $1.59K. The position accounts for ﹤0.01% of the portfolio, ranked #529.
Adirondack Trust Company first reported a position in NVCR in Q3 2019 and has held it in 29 quarters since. The position peaked at $22K in Q2 2021. 15 funds tracked by Wall St. Rank hold NVCR as of Q3 2026.
- Adirondack Trust Company held 100 shares of NovoCure worth $1.59K as of Q3 2026.
- Adirondack Trust Company left its NovoCure share count unchanged in Q3 2026.
- NovoCure made up ﹤0.01% of Adirondack Trust Company's portfolio in Q3 2026, its #529 holding.
- Adirondack Trust Company first reported a position in NovoCure in Q3 2019 and has held it in 29 quarters since.
- Adirondack Trust Company's NovoCure position peaked at $22K in Q2 2021.
- 15 funds tracked by Wall St. Rank held NovoCure as of Q3 2026.
Based on Adirondack Trust Company's 13F filing for Q3 2026, filed 14 Oct 2026.